Poland· PL-100070931
Vitalipid N Infant
A vitamins product containing preparat złożony, registered in Poland by Fresenius Kabi AB. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Preparat złożony is registered in 11 of 19 countries.
Countries holding a registration under ATC B05XC (vitamins), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Preparat złożony · ATC B05XC
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Preparat złożony
- Manufacturer
- Fresenius Kabi AB
- Country
- Poland (PL)
- ATC code
- B05XC
- ATC class
- Vitamins
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990272013
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under B05XC
Vitamins, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ffb719ad-7af2-43d0-a2bb-460db9ce71e9 GET /v1/drugs/ffb719ad-7af2-43d0-a2bb-460db9ce71e9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Koncentrat do sporządzania emulsji do infuzji",
"source": "urpl",
"strength": "-",
"packaging": "05909990272013 ¦ Lz ¦ 10677\n10 amp. 10 ml",
"substance": "Retinoli palmitas 135.3 mcg + Fitomenadion 20 mcg + Ergocalciferol 1 mcg + int-rac-alfa-Tocopherolum 0.64 mg",
"common_name": "Preparat złożony",
"pl_product_id": "100070931",
"pozwolenie_nr": "02720",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about preparat złożony.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.